FDA: antique of ’93 [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-12-11 16:29 (2547 d 15:07 ago) – Posting: # 12039
Views: 8,205

Hi John,

» » BTW: Your partial replicate nightmare (#10563). Did you receive an answer from Mr Schuirmann?
»
» Nope. I emailed him two questions and no feedback so far (2nd one was about stats for a partial rep study having 2 groups).

So far? Unbelievable. Ask your legal department to get refund from the FDA for the study you performed exactly following the guidance only to get from SAS:

WARNING: Did not converge.
WARNING: Output 'Estimates' was not created.


Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,226 posts in 4,427 threads, 1,482 registered users;
online 16 (0 registered, 16 guests [including 15 identified bots]).
Forum time: Wednesday 07:37 CET (Europe/Vienna)

A big data-analyst is an expert
in producing misleading conclusions from huge datasets.
It is much more efficient to use a statistician,
who can do the same with small ones.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5